AMNIOTX
Live / Applied — Statement of use — registration review complete (as of 19 Aug 2026)
What this means for you
Not registered yet, but its 30 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97483331
- Mark type
- Stylized text
- Filed
- 30 Jun 2022
- Published for opposition
- 30 May 2023
- Attorney of record
- Ryan D. Artis
Goods and services
- Class 005 — Pharmaceuticals: Biological tissue, namely, amnion tissue for wound care and surgical use
Owner
- BioSTAR Medical, LLC, Willowbrook, IL, US
- BioSTAR Medical, LLC, Willowbrook, IL, US
Prosecution history
- 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 19 Aug 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Aug 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Jul 2026 — USE AMENDMENT FILED
- 27 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
- 17 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2026 — SOU EXTENSION 5 GRANTED
- 25 Jan 2026 — SOU EXTENSION 5 FILED
- 16 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jul 2025 — SOU EXTENSION 4 GRANTED
- 25 Jul 2025 — SOU EXTENSION 4 FILED